426 related articles for article (PubMed ID: 14964727)
1. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow.
Meinel L; Karageorgiou V; Fajardo R; Snyder B; Shinde-Patil V; Zichner L; Kaplan D; Langer R; Vunjak-Novakovic G
Ann Biomed Eng; 2004 Jan; 32(1):112-22. PubMed ID: 14964727
[TBL] [Abstract][Full Text] [Related]
2. Bone and cartilage tissue constructs grown using human bone marrow stromal cells, silk scaffolds and rotating bioreactors.
Marolt D; Augst A; Freed LE; Vepari C; Fajardo R; Patel N; Gray M; Farley M; Kaplan D; Vunjak-Novakovic G
Biomaterials; 2006 Dec; 27(36):6138-49. PubMed ID: 16895736
[TBL] [Abstract][Full Text] [Related]
3. Bioreactor culture duration of engineered constructs influences bone formation by mesenchymal stem cells.
Mitra D; Whitehead J; Yasui OW; Leach JK
Biomaterials; 2017 Nov; 146():29-39. PubMed ID: 28898756
[TBL] [Abstract][Full Text] [Related]
4. Engineering cartilage-like tissue using human mesenchymal stem cells and silk protein scaffolds.
Meinel L; Hofmann S; Karageorgiou V; Zichner L; Langer R; Kaplan D; Vunjak-Novakovic G
Biotechnol Bioeng; 2004 Nov; 88(3):379-91. PubMed ID: 15486944
[TBL] [Abstract][Full Text] [Related]
5. Spatial regulation of human mesenchymal stem cell differentiation in engineered osteochondral constructs: effects of pre-differentiation, soluble factors and medium perfusion.
Grayson WL; Bhumiratana S; Grace Chao PH; Hung CT; Vunjak-Novakovic G
Osteoarthritis Cartilage; 2010 May; 18(5):714-23. PubMed ID: 20175974
[TBL] [Abstract][Full Text] [Related]
6. In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells.
Wang Y; Kim UJ; Blasioli DJ; Kim HJ; Kaplan DL
Biomaterials; 2005 Dec; 26(34):7082-94. PubMed ID: 15985292
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive time-lapsed monitoring and quantification of engineered bone-like tissue.
Hagenmüller H; Hofmann S; Kohler T; Merkle HP; Kaplan DL; Vunjak-Novakovic G; Müller R; Meinel L
Ann Biomed Eng; 2007 Oct; 35(10):1657-67. PubMed ID: 17546503
[TBL] [Abstract][Full Text] [Related]
8. Effects of chondrogenic and osteogenic regulatory factors on composite constructs grown using human mesenchymal stem cells, silk scaffolds and bioreactors.
Augst A; Marolt D; Freed LE; Vepari C; Meinel L; Farley M; Fajardo R; Patel N; Gray M; Kaplan DL; Vunjak-Novakovic G
J R Soc Interface; 2008 Aug; 5(25):929-39. PubMed ID: 18230586
[TBL] [Abstract][Full Text] [Related]
9. Scaffold-free bioprinted osteogenic and chondrogenic systems to model osteochondral physiology.
Breathwaite EK; Weaver JR; Murchison AC; Treadwell ML; Odanga JJ; Lee JB
Biomed Mater; 2019 Oct; 14(6):065010. PubMed ID: 31491773
[TBL] [Abstract][Full Text] [Related]
10. Nano-ceramic composite scaffolds for bioreactor-based bone engineering.
Lv Q; Deng M; Ulery BD; Nair LS; Laurencin CT
Clin Orthop Relat Res; 2013 Aug; 471(8):2422-33. PubMed ID: 23436161
[TBL] [Abstract][Full Text] [Related]
11. Fractionated human adipose tissue as a native biomaterial for the generation of a bone organ by endochondral ossification.
Guerrero J; Pigeot S; Müller J; Schaefer DJ; Martin I; Scherberich A
Acta Biomater; 2018 Sep; 77():142-154. PubMed ID: 30126590
[TBL] [Abstract][Full Text] [Related]
12. Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds.
Meinel L; Karageorgiou V; Hofmann S; Fajardo R; Snyder B; Li C; Zichner L; Langer R; Vunjak-Novakovic G; Kaplan DL
J Biomed Mater Res A; 2004 Oct; 71(1):25-34. PubMed ID: 15316936
[TBL] [Abstract][Full Text] [Related]
13. Condensation-Driven Chondrogenesis of Human Mesenchymal Stem Cells within Their Own Extracellular Matrix: Formation of Cartilage with Low Hypertrophy and Physiologically Relevant Mechanical Properties.
Yang Y; Liu Y; Lin Z; Shen H; Lucas C; Kuang B; Tuan RS; Lin H
Adv Biosyst; 2019 Dec; 3(12):e1900229. PubMed ID: 32648682
[TBL] [Abstract][Full Text] [Related]
14. Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds.
Hofmann S; Hagenmüller H; Koch AM; Müller R; Vunjak-Novakovic G; Kaplan DL; Merkle HP; Meinel L
Biomaterials; 2007 Feb; 28(6):1152-62. PubMed ID: 17092555
[TBL] [Abstract][Full Text] [Related]
15. Chondrogenesis in perfusion bioreactors using porous silk scaffolds and hESC-derived MSCs.
Tiğli RS; Cannizaro C; Gümüşderelioğlu M; Kaplan DL
J Biomed Mater Res A; 2011 Jan; 96(1):21-8. PubMed ID: 20949478
[TBL] [Abstract][Full Text] [Related]
16. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis.
Bosnakovski D; Mizuno M; Kim G; Takagi S; Okumura M; Fujinaga T
Biotechnol Bioeng; 2006 Apr; 93(6):1152-63. PubMed ID: 16470881
[TBL] [Abstract][Full Text] [Related]
17. Flow perfusion culture of human mesenchymal stem cells on silicate-substituted tricalcium phosphate scaffolds.
Bjerre L; Bünger CE; Kassem M; Mygind T
Biomaterials; 2008 Jun; 29(17):2616-27. PubMed ID: 18374976
[TBL] [Abstract][Full Text] [Related]
18. A proteomic analysis of chondrogenic, osteogenic and tenogenic constructs from ageing mesenchymal stem cells.
Peffers MJ; Collins J; Loughlin J; Proctor C; Clegg PD
Stem Cell Res Ther; 2016 Sep; 7(1):133. PubMed ID: 27624072
[TBL] [Abstract][Full Text] [Related]
19. Assessment of human ovarian follicular fluid derived mesenchymal stem cells in chitosan/PCL/Zn scaffold for bone tissue regeneration.
Chandramohan Y; Jeganathan K; Sivanesan S; Koka P; Amritha TMS; Vimalraj S; Dhanasekaran A
Life Sci; 2021 Jan; 264():118502. PubMed ID: 33031825
[TBL] [Abstract][Full Text] [Related]
20. Chondrogenic differentiation of human bone marrow mesenchymal stem cells in chitosan-based scaffolds using a flow-perfusion bioreactor.
Alves da Silva ML; Martins A; Costa-Pinto AR; Correlo VM; Sol P; Bhattacharya M; Faria S; Reis RL; Neves NM
J Tissue Eng Regen Med; 2011 Oct; 5(9):722-32. PubMed ID: 21953870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
